(via TheNewswire)
11 February2022 –TheNewswire -
Share Option Summary
The Share Options have been granted under the Company’s 2019 Share Option Scheme, which was adopted by shareholders at the Annual General Meeting in
Table 1. Share Option Summary
Date of grant | |
Closing market price on AIM on date of grant | £0.585 |
Share Options validity period | 5 years |
Share Options vesting period | Up to 18 months |
Grant A: Exercise price per Ordinary Share | £0.65 |
Grant A: Number of Ordinary Shares subject to Share Options granted | 3,125,000 |
Grant B: Exercise price per Ordinary Share | £0.7315 |
Grant B: Number of Ordinary Shares subject to Share Options granted | 300,000 |
Total Number of Ordinary Shares subject to Share Options granted | 3,425,000 |
Share Option Vesting Conditions
For executive Directors and employees, the Share Options vest in two equal tranches at 12 months and 18 months from the date of grant. Vesting is conditional on the holder remaining with the Company during the relevant period. For non-executive Directors, the Share Options vest in a single tranche on the date of grant.
Share Options Granted to Directors and PDMR
Share Options to purchase a total of 2,450,000 Ordinary Shares were granted to Directors and those employees considered as a Person Discharging Managerial Responsibilities (“PDMR”). The balance of the Share Options (to purchase 975,000 Ordinary Shares) were granted to Company employees and consultants.
Table 2: Share Options Granted to Directors and PDMR
PDMR | Position | Number of Ordinary Shares subject to Share Options granted | Number of Ordinary Shares subject to Share Options granted as a % of the Company’s current issued share capital |
Non-Executive Chairman | 250,000 | 0.21% | |
Non-Executive Director | 175,000 | 0.15% | |
Non-Executive Director | 200,000 | 0.17% | |
Non-Executive Director | 175,000 | 0.15% | |
Chief Executive & Director | 500,000 | 0.43% | |
Executive Director | 300,000 | 0.26% | |
Chief Investment Officer | 300,000 | 0.26% | |
Chief Financial Officer | 150,000 | 0.13% | |
General Counsel | 100,000 | 0.09% | |
Amilha Young | Legal Counsel & Company Secretary | 100,000 | 0.09% |
VP Operations | 100,000 | 0.09% | |
Senior Consultant Geologist | 100,000 | 0.09% | |
Total | 2450000 | 2.12 | |
Notes:
|
Notification and public disclosure of transactions by PDMRs and persons closely associated with them.
1 | Details of the Person Discharging Managerial Responsibilities / persons closely associated | |
a) |
| |
2 | Reason for the notification | |
a) | Position/status |
|
b) | Initial notification/ Amendment | Initial notification |
3 | Details of the issuer emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | ||
b) | LEI | 2138001P93D9LMFIUA28 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument | Ordinary Shares of |
b) | Identification code | GB00BJ9TYB96 |
c) | Nature of the transaction | Grant of Share Options |
d) | Price(s) and volume(s) | Price for all grants £0.65 Volumes
|
e) | Aggregated information | |
Aggregated volume Price | Share Options: 2,450,000 Exercise price: £0.65 | |
f) | Date of the transactions | |
g) | Place of the transactions | Off market |
For further information you are invited to visit the Company’s websitewww.altus-strategies.comor contact:
Tel:+44 (0) 1235 511 767 E-mail:info@altus-strategies.com | |
Tel:+44 (0) 20 3470 0470 | |
Tel:+44 (0) 20 3470 0471 Tel:+44 (0) 20 3470 0535 | |
Tel:+44 (0) 20 7186 9927 | |
Yellow Jersey PR (Financial PR & IR) | Tel:+44 (0) 20 3004 9512 E-mail:altus@yellowjerseypr.com |
About
TSX Venture Exchange Disclaimer
Neither the
Market Abuse Regulation Disclosure
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of
**END**
Copyright (c) 2022 TheNewswire - All rights reserved.
Copyright (c) 2022 TheNewswire - All rights reserved., source